Abstract
There is compelling evidence for tomatoes to be considered as cardiovascular protective foods, due to the presence in tomatoes of many nutrients which have been associated with theoretical or proven effects on the cardiovascular system. However, despite an inverse association found for high intakes of tomato-based products, dietary lycopene was not strongly associated with the risk of cardiovascular disease (CVD). This indicates that other unidentified compounds in tomatoes may have cardioprotective effects. We identified potent anti-platelet factors in tomato extracts, which inhibited platelet aggregation and discussed recent patents in this field. There is increasing evidence that acute clinical manifestations of coronary atherosclerotic disease are caused by plaque disruption and subsequent plateletthrombus formation. Platelet activity can influence the progression of disease as well as the stability of atherosclerotic plaques. The observed cardiovascular benefits attributed to the tomato could be linked to antiplatelet activity and thus suppression of platelet function in vivo. This type of natural anti-thrombotic agent could have an application in primary prevention of CVD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
